Development of XYD113 as a potent and highly selective GSPT1 degrader for cancer therapy
Shen Hui, Luo Xiao-yu, Jing Xin-yi, Jin Wei-qin, Xu Hong-rui, Hu Jian-kang, Zhong Zhi-xin, Zhang Jian, Liang Hao-zhao, Zhuang Xiao-xi, Ge Hong-hua, Smaill Jeff B., Xu Jin-xin, Zhang Yan, Patterson Adam V., Ma Jin-ming, Xu Yong
Journal：ACTA PHARMACOLOGICA SINICA
IF：10.4
DOI：10.1038/s41401-026-01856-z
PMID：
Published：2026-06-23
research field：肿瘤学分子生物学药理学癌症治疗学药物研发靶向蛋白降解生物化学
Abstract
本文使用的Yeasen产品
相关产品
